Purpose Describe the development, delivery, acceptability and evaluation of a modular training programme for community-based, non-medical practitioners monitoring patients with quiescent neovascular age related macular degeneration (QnAMD). Also, report on a qualitative process evaluation conducted during the pilot phase of a randomised control trial (the FENETRE Study) exploring patient and practitioner acceptability of community-based QnAMD care relative to hospital-based care. Methods Learning outcomes from The College of Optometrists’ Medical Retina higher qualifications and the Royal College of Ophthalmologists’ Common Clinical Competency Framework were used to develop a competency framework for QnAMD care. Training was delivered ...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
Objectives: To assess general patient knowledge of age-related macular degeneration (AMD), including...
Funding Information: The author(s) have made the following disclosure(s): R.G.: Personal fees ? Heid...
Purpose Describe the development, delivery, acceptability and evaluation of a modular training prog...
PurposeDescribe the development, delivery, acceptability and evaluation of a modular training progra...
Objective Management of age-related macular degeneration (AMD) places a high demand on already const...
OBJECTIVE: Management of age-related macular degeneration (AMD) places a high demand on already cons...
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular...
Background Patients with neovascular age-related macular degeneration (nAMD) usually attend regular ...
IntroductionStandard treatment for neovascular age-related macular degeneration (nAMD) is intravitre...
Background/Objective To explore acceptability by patients and health care professionals of a new su...
Objectives: To compare the ability of ophthalmologists versus optometrists to correctly classify ret...
Aims: This study aims to quantify the diagnostic test-accuracy of three visual function self-monitor...
This report summarises our evaluation of four different pathfinder services for people with wet Age ...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
Objectives: To assess general patient knowledge of age-related macular degeneration (AMD), including...
Funding Information: The author(s) have made the following disclosure(s): R.G.: Personal fees ? Heid...
Purpose Describe the development, delivery, acceptability and evaluation of a modular training prog...
PurposeDescribe the development, delivery, acceptability and evaluation of a modular training progra...
Objective Management of age-related macular degeneration (AMD) places a high demand on already const...
OBJECTIVE: Management of age-related macular degeneration (AMD) places a high demand on already cons...
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular...
Background Patients with neovascular age-related macular degeneration (nAMD) usually attend regular ...
IntroductionStandard treatment for neovascular age-related macular degeneration (nAMD) is intravitre...
Background/Objective To explore acceptability by patients and health care professionals of a new su...
Objectives: To compare the ability of ophthalmologists versus optometrists to correctly classify ret...
Aims: This study aims to quantify the diagnostic test-accuracy of three visual function self-monitor...
This report summarises our evaluation of four different pathfinder services for people with wet Age ...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
Objectives: To assess general patient knowledge of age-related macular degeneration (AMD), including...
Funding Information: The author(s) have made the following disclosure(s): R.G.: Personal fees ? Heid...